Among the four mutated genes described above (i.e., NCOR1, MUC16, MUC4, and RSPO2), NCOR1, MUC16, and MUC4 were reported to have been directly involved in modulating tumor microenvironment and thereby mediating drug resistance [35,36,37]. The gene discussed is NCOR1; the disease is neoplasm.